v3.26.1
Stockholder's Equity (Tables)
6 Months Ended
Mar. 31, 2026
Stockholder's Equity [Abstract]  
Schedule of Option Activity

A summary of option activity under the stock plans is presented below:

 

   Shares   Weighted-
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual
Term
  Aggregate
Intrinsic
Value
 
Outstanding at September 30, 2025   18,100,000   $1.83   8.21 years  $5,386,000 
Granted   
-
    
-
         
Forfeited   
-
    
-
         
Outstanding at March 31, 2026   18,100,000   $1.83   7.52 years  $
-
 
Exercisable at March 31, 2026   11,502,083   $1.89   7.30 years  $
-
 
Schedule of Warrants Outstanding

We have reserved 38,653,029 shares of common stock for the exercise of outstanding warrants. The following table summarizes the warrants outstanding at March 31, 2026:

 

   Exercise
Price
   Number   Expiration Dates
July 2025 Offering Investors  $1.09    6,818,182   January 20, 2031
July 2025 Offering Agent  $1.65    272,727   July 17, 2030
July 2025 Prior Offering Agent  $1.65    477,273   July 17, 2030
September 2025 Offering Investors  $1.09    5,142,858   January 20,2031
September 2025 Offering Agent  $1.92    205,714   March 10, 2031
September 2025 Prior Offering Agent  $2.1875    360,000   March 10, 2031
December 2025 Offering Investors  $0.0001    7,046,000   None
December 2025 Offering Investors  $1.09    16,513,762   January 20, 2031
December 2025 Placement Offering Agent  $1.3625    1,155,963   December 8, 2030
December 2025 Prior Offering Agent  $1.199    660,550   December 8, 2030
         38,653,029    
Schedule of Common Stock Reserved for Future Issuances

A summary of common stock reserved for future issuances by the Company as of March 31, 2026 is as follows:

 

Stock plan options outstanding   18,100,000 
Restricted stock awards   11,950,000 
Stock plan shares available for future grants   14,950,000 
Warrants outstanding   38,653,029 
Total   83,653,029